Depreciation in USD of Nuo Therapeutics, Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Nuo Therapeutics, Inc. quarterly and annual Depreciation history and change rate from 2011 to Q3 2025.
  • Nuo Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $23,148, a 483% increase year-over-year.
  • Nuo Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $73,067, a 378% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Depreciation for 2024 was $23,022, a 50.2% increase from 2023.
  • Nuo Therapeutics, Inc. annual Depreciation for 2023 was $15,327, a 125% increase from 2022.
  • Nuo Therapeutics, Inc. annual Depreciation for 2022 was $6,827.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Nuo Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $73,067 $23,148 +$19,176 +483% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $53,891 $23,056 +$19,289 +512% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $34,602 $15,347 +$11,580 +307% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $23,022 $11,516 +$7,749 +206% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q3 2024 $15,273 $3,972 +$300 +8.2% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $14,973 $3,767 -$20 -0.53% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $14,993 $3,767 -$334 -8.1% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 $15,327 $3,767 +$999 +36% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 $14,328 $3,672 +$969 +36% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $13,359 $3,787 +$2,431 +179% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $10,928 $4,101 +$4,101 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $6,827 $2,768 +$2,768 01 Oct 2022 31 Dec 2022 10-K 19 Apr 2024 2023 FY
Q3 2022 $4,059 $2,703 +$2,703 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $1,356 $1,356 +$1,356 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $0 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $0 $0 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-Q/A 10 Aug 2022 2022 Q2
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2019 $100,000 $24,000 -$1,000 -4% 01 Jul 2019 30 Sep 2019 10-Q 31 Jan 2020 2019 Q3
Q2 2019 $101,000 $26,000 $0 0% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 $101,000 $25,000 -$1,000 -3.8% 01 Jan 2019 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $102,000 $25,000 01 Oct 2018 31 Dec 2018 10-K 16 Apr 2019 2018 FY
Q3 2018 $25,000 01 Jul 2018 30 Sep 2018 10-Q 31 Jan 2020 2019 Q3
Q2 2018 $26,000 01 Apr 2018 30 Jun 2018 10-Q 19 Aug 2019 2019 Q2
Q1 2018 $26,000 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019 2019 Q1
Q1 2013 $241,400 01 Jan 2013 31 Mar 2013 10-Q 09 May 2013 2013 Q1

Nuo Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $23,022 +$7,695 +50% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 $15,327 +$8,500 +125% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 $6,827 +$6,827 01 Jan 2022 31 Dec 2022 10-K 19 Apr 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2018 $102,000 -$160,000 -61% 01 Jan 2018 31 Dec 2018 10-K 16 Apr 2019 2018 FY
2017 $262,000 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2012 $823,000 +$459,000 +126% 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2013 2012 FY
2011 $364,000 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.